Isoflavone-Rich Extract of Trifolium resupinatum: Anti-obesity Attributes with In Silico Investigation of Its Constituents

Mona M. Marzouk,Alia Y. Ragheb,Elham M. Youssef,Nermin A. Ragab,Eman M. El-Taher,Ibrahim A. El Garf,Mona E. S. Kassem
DOI: https://doi.org/10.1007/s43450-023-00501-8
2024-01-02
Revista Brasileira de Farmacognosia
Abstract:Abstract Trifolium resupinatum L., Fabaceae, aqueous methanol leaf extract was selected to mitigate some obesity-associated risk factors to validate the possibility of further developing herbal drugs. Chromatography and spectrophotometric techniques verified 14 phenolics, five of which were first isolated from the plant and identified as 6''- O -acetyl ononin, genistin, daidzin, sissotrin, and astragalin. Further phytochemical characterization was performed via liquid chromatography-electrospray ionization-mass spectrometry assisted by a spectral similarity molecular network. In total, 81 metabolites were tentatively annotated including 69 species-first dereplications. Two major isolates (formononetin and pseudobaptigenin) were selected along with the investigated extract for an in vitro pancreatic lipase inhibition assay. They showed notable effects with IC 50 values (μg/ml): 47.2 ± 1.1, 112.8 ± 1.23, and 471.32 ± 0.8, respectively, incomparable to orlistat (23.8 ± 0.64). Preliminary in vivo assay (25 mg/kg extract, daily, 8 weeks) displayed weight loss interest and promising advancement of serum triacylglycerides, total cholesterol, and glucose levels. Molecular docking studies confirmed the promising binding score of formononetin and pseudobaptigenin near the active sites and highlighted the affinity of other isolates to the lipase enzyme. Several isolates passed Lipinski’s law of the drug-likeness test, whereas SwissADME radar displayed that all constituents fall within the acceptable bioavailability zone. Therefore, the combination of flavonoids, especially isoflavones, could be regarded as drug-like agents for protection against obesity-induced metabolic complaints. Graphical Abstract
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the potential of isoflavone - rich extracts from the leaves of Trifolium resupinatum L. in reducing obesity - related risk factors and to verify the possibility of its further development as a potential herbal medicine. Specifically, the research mainly focuses on the following aspects: 1. **Chemical component analysis**: Through chromatographic and spectroscopic techniques, 14 phenolic compounds were isolated and identified from the methanol - water extract of Trifolium resupinatum L. leaves, among which 5 were isolated and identified from this plant for the first time as 6'' - O - acetylallioside, genistin, daidzin, sisotrin and kaempferol - 3 - O - glucoside. 2. **Pancreatic lipase inhibitory activity**: Two major isolates (formononetin and pseudobaptigenin) and the extract in the study were selected for in vitro pancreatic lipase inhibition tests. The results showed that these compounds had a significant inhibitory effect, but there was still a gap compared with orlistat. 3. **In vivo experimental evaluation**: Preliminary in vivo experiments (25 mg/kg of extract per day for 8 weeks) showed that the extract had a positive impact on weight loss and the improvement of serum triacylglycerol, total cholesterol and blood glucose levels. 4. **Molecular docking study**: Through molecular docking studies, the binding scores of formononetin and pseudobaptigenin near the active site of pancreatic lipase were confirmed, and the affinity of other isolates for lipase enzymes was emphasized. 5. **Drug property evaluation**: The SwissADME radar chart showed that all isolates were within the acceptable bioavailability range, and some isolates passed Lipinski's drug - likeness test. In summary, this study aims to explore the potential application value of Trifolium resupinatum L. leaf extract and its main components in anti - obesity and provide a scientific basis for its further development as a herbal medicine.